These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3162444)

  • 21. An assessment of the clinical usefulness of two serum markers, CA15 3 and HMFG 2 in localized and metastatic breast cancer.
    Bliss P; Fisken J; Roulsten J; Leonard RC
    Dis Markers; 1993 Jun; 11(1):45-8. PubMed ID: 8358965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody].
    Suzuki H; Teshima K; Noda K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An immunosorbent assay for blood group I antigens in breast carcinoma.
    Dube VE; Kallio P; Chmiel JS; Haid M; Hakim A
    Clin Immunol Immunopathol; 1987 Nov; 45(2):196-207. PubMed ID: 3665200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of the cluster 1 and mucin antigens in human small cell lung cancer and other epithelial tumour cell lines after treatment with the differentiation inducing agent, sodium butyrate.
    Hay FG; Duncan LW; Langdon SP; Leonard RC
    Br J Cancer Suppl; 1991 Jun; 14():33-5. PubMed ID: 1645568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and biochemical characterisation of a novel breast carcinoma associated mucin-like glycoprotein defined by antibody 3E1.2.
    Stacker SA; Tjandra JJ; Xing PX; Walker ID; Thompson CH; McKenzie IF
    Br J Cancer; 1989 Apr; 59(4):544-53. PubMed ID: 2469454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The value of the human milk fat globule membrane antigen HMFG2 in epithelial ovarian cancer monitoring: comparison with CA125.
    Fisken J; Roulston JE; Sturgeon C; Badley RA; Jönrup I; Aspinall L; Leonard RC
    Br J Cancer; 1993 May; 67(5):1065-70. PubMed ID: 8494699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Tumor-associated antigens and fibrin derivatives as reaction products of ovarian cancer].
    Schröck R; Hafter R; Schmid L; Babic R; Ulm K; Gössner W; Graeff H
    Geburtshilfe Frauenheilkd; 1986 Jan; 46(1):1-10. PubMed ID: 2420679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MAM-6 antigen, a new serum marker for breast cancer monitoring.
    Hilkens J; Kroezen V; Bonfrer JM; De Jong-Bakker M; Bruning PF
    Cancer Res; 1986 May; 46(5):2582-7. PubMed ID: 3697998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carcinoma-associated mucin serum markers CA M26 and CA M29: efficacy in detecting and monitoring patients with cancer of the breast, colon, ovary, endometrium and cervix.
    Yedema KA; Kenemans P; Wobbes T; van Kamp GJ; de Bruijn HW; Thomas CM; Massuger LF; Schijf CP; Bon GG; Vermorken JB
    Int J Cancer; 1991 Jan; 47(2):170-9. PubMed ID: 1988362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels and biochemical characteristics of cancer-associated antigen CA-549, a circulating breast cancer marker.
    Bray KR; Koda JE; Gaur PK
    Cancer Res; 1987 Nov; 47(22):5853-60. PubMed ID: 2444335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of monoclonal antibody-defined tumor markers in four carcinomas.
    Wu JT
    Ann Clin Lab Sci; 1989; 19(1):17-26. PubMed ID: 2916833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioimmunoassay of the CA 12 5 antigen in ovarian carcinomas: advantages compared with CA 19-9 and CEA.
    Ricolleau G; Chatal JF; Fumoleau P; Kremer M; Douillard JY; Curtet C
    Tumour Biol; 1984; 5(3-4):151-9. PubMed ID: 6594738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new immunoassay using monoclonal antibodies HMFG1 and HMFG2 together with an existing marker CA125 for the serological detection and management of epithelial ovarian cancer.
    Dhokia B; Canney PA; Pectasides D; Munro AJ; Moore M; Wilkinson PM; Self C; Epenetos AA
    Br J Cancer; 1986 Dec; 54(6):891-5. PubMed ID: 3467785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer.
    Allard WJ; Neaman IE; Elting JJ; Barnett TR; Yoshimura H; Fritsche HA; Yeung KK
    Cancer Res; 1994 Mar; 54(5):1227-34. PubMed ID: 8118811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new monoclonal antibody to epithelial membrane antigen (EMA)-E29. A comparison of its immunocytochemical reactivity with polyclonal anti-EMA antibodies and with another monoclonal antibody, HMFG-2.
    Heyderman E; Strudley I; Powell G; Richardson TC; Cordell JL; Mason DY
    Br J Cancer; 1985 Sep; 52(3):355-61. PubMed ID: 3899156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Significance of CA 125 antigen levels in patients with ovarian cancer].
    Shimizu Y; Fujiwara H; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Okudaira Y
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical use of CA 125 and its combination assay with other tumor marker in patients with ovarian carcinoma.
    Negishi Y; Furukawa T; Oka T; Sakamoto M; Hirata T; Okabe K; Matayoshi K; Akiya K; Soma H
    Gynecol Obstet Invest; 1987; 23(3):200-7. PubMed ID: 3474196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of monoclonal-antibody-defined antigens in fractions isolated from human breast carcinomas and patients' serum.
    Croce MV; Price MR; Segal-Eiras A
    Cancer Immunol Immunother; 1995 Feb; 40(2):132-7. PubMed ID: 7882384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.
    Hayes DF; Zurawski VR; Kufe DW
    J Clin Oncol; 1986 Oct; 4(10):1542-50. PubMed ID: 2428949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The expression of milk fat globule antigens within human mammary tumours: relationship to steroid hormone receptors and response to endocrine treatment.
    Baildam AD; Howell A; Barnes DM; Turnbull L; Sellwood RA
    Eur J Cancer Clin Oncol; 1989 Mar; 25(3):459-67. PubMed ID: 2703000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.